Drugs / fecal microbiota transplantation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05739864 | Feb 2023 → Feb 2027 expected | ulcerative colitis | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fecal microbiota transplantation | “fecal microbiota transplantation (FMT) has been established as a highly effective option in the treatment of recurrent Clostridioides difficile infection (rCDI)” NCT05739864 ↗ |
| Known as | FMT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05739864 ↗ |